Anticoagulation & Antiinflammatory Management for Endoscopy
Anticoagulation & Antiinflammatory Management for Endoscopy
(Gastrointest Endosc 2005;61:189-194)
WARFARIN THERAPY
HIGH-RISK PATIENTS: Afib associated with valvular disease Mechanical valve in the mitral position Mechanical valve and prior thromboembolic event
LOW-RISK PATIENTS: DVT Uncomplicated or paroxysmal Afib Bioprosthetic valve Mechanical valve in aortic position
HIGH-RISK PROCEDURES: Polypectomy Biliary Sphincterotomy Pneumatic or Bougie dilation PEG ERCP/EUS with FNA Laser ablation and coagulation Treatment of varices
Stop warfarin 3-5 days before; Consider heparin while INR below therapeutic
Stop warfarin 3-5 days before Restart warfarin after procedure
LOW RISK PROCEDURES: Diagnostic: EGD/Cscope/Flex Sig ± Biopsy ERCP without Sphincterotomy Biliary/Pancreatic stent without endoscopic sphincterotomy EUS without FNA Enteroscopy
No change in anticoagulation; Elective procedures should be delayed while INR is supratherapeutic
Only gold members can continue reading. Log In or Register to continue